Company Comparison
Foundation Medicine vs 23andMe
Side-by-side comparison of two portfolio companies — sector, funding stage, investors, valuation, and more.
| Metric | Foundation Medicine | 23andMe |
|---|---|---|
| Sector | Biotech | Biotech |
| Headquarters | Boston, Massachusetts | South San Francisco, California |
| Founded | 2010 | 2006 |
| Status | Active | Active |
| Last Funding Stage | IPO | — |
| Total Funding | $456M | — |
| Valuation | — | — |
What They Build
Foundation Medicine
Foundation Medicine, Inc. is an American company based in Boston, Massachusetts, which develops, manufactures, and sells genomic profiling assays based on next-generation sequencing technology for solid tumors, hematologic malignancies, and sarcomas.
23andMe
23andMe Holding Co. is an American personal genomics and biotechnology company based in South San Francisco, California.
Key Investors
Sector Overlap
Both Foundation Medicine and 23andMe operate in Biotech.
Browse all Biotech companies →Websites
The operating system for private capital.
Archstone runs the back office for venture, PE, real estate, and credit funds — LP reporting, capital calls, portfolio tracking, and fund accounting, in one platform. Now in alpha.
Now in alpha with select funds. 14-day trial available.